Brain implant learns to read OCD signals in real time
NCT ID NCT04281134
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an adaptive deep brain stimulation (aDBS) system in just 3 people with severe, treatment-resistant OCD. The device is implanted in the brain and chest, and it aims to detect brain signals linked to OCD distress and adjust stimulation automatically. The main goal is to see if the system can reliably identify those signals, not yet to prove it improves symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Deep brain stimulation (DBS) device
- What this could lead to
- If it works, this could point toward a smarter, more personalized DBS system that adjusts stimulation in real time to better control severe OCD symptoms.
- What could go wrong
- This is a very early, tiny study (only 3 participants) focused on finding brain signals, not on proving the treatment works. The approach may not lead to a reliable therapy, and DBS surgery carries risks like infection or brain injury.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
3 people
The number who actually took part.
- Started
-
Oct 2019
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * OCD DBS Subject Inclusion criteria: 1. Signed informed consent prior to any study specific procedures being performed 2. Male or female between ages 21 and 70; 3. At least a five-year history of treatment-refractory OCD that causes substantial subjective distress and impairment in functioning; 4. Y-BOCS minimum score of 28; 5. Failed an adequate trial of at least three of the following SSRIs: Fluoxetine; fluvoxamine; citalopram; escitalopram; sertraline; paroxetine; 6. Failed an adequate trial of clomipramine; 7. Failed augmentation of one or more of the aforementioned drugs with at least one of the following antipsychotics: haloperidol; risperidone; quetiapine; ziprasidone; aripiprazole; 8. Failed an adequate trial of CBT for OCD, defined as 25 hours of documented exposure and response prevention (ERP) by an expert therapist; 9. Stable psychotropic medical regimen for the month preceding surgery Non-Implanted Control Subject Inclusion criteria: 1. Signed informed consent prior to any study specific procedures being performed 2. Male or female between ages 21 and 70 Exclusion Criteria: * OCD DBS Subject Exclusion criteria: 1. Inability or refusal to give informed consent. 2. Lifetime diagnosis of psychotic disorders such as schizophrenia; 3. Alcohol or substance abuse/dependence within 6 months, excluding nicotine; 4. Deemed at high risk of suicidal behavior or impulsivity, per clinical opinion assessments. 5. Any Neurological/Medical condition that makes the subject, in the opinion of the surgeon, a poor candidate. 6. Pregnant (confirmed by serum pregnancy test on females of child bearing age) or plans to become pregnant in the next 24 months. 7. Need for Diathermy 8. Contraindications to MRI Non-Implanted Control Subject Exclusion criteria: 1. Inability or refusal to give informed consent. 2. Lifetime diagnosis of mental illness 3. A score of 8 or greater on part B of the Florida Obsessive Compulsive Inventory 4. Any neurological disorders (i.e., MS, Parkinson's Disease, seizure disorders, etc.) or evidence of brain abnormalities/injury, such as tumor, stroke, or traumatic brain injury 5. Pregnant (confirmed by self-report for females of child bearing age) 6. Contraindications to MRI
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obsessive compulsive disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Brown University
Providence, Rhode Island, 02912, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15260, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Brain scans and biosamples: mapping why OCD looks so different in every person
- Can a gentle electrical current quiet Obsessive-Compulsive symptoms?
- Can magnetic pulses ease OCD in teens who Haven't improved?
- Can a focused electric field quiet the Brain's obsessive signals?
- Can tailored brain stimulation quiet anxiety that drugs Can't?